Call Options

6 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$3.4 - $4.42 $336,260 - $437,138
98,900 New
98,900 $380,000
Q1 2022

May 17, 2022

SELL
$12.92 - $27.18 $1.9 Million - $4.01 Million
-147,400 Reduced 67.8%
70,000 $1.23 Million
Q4 2021

Feb 15, 2022

SELL
$21.96 - $42.69 $1.36 Million - $2.65 Million
-62,100 Reduced 22.22%
217,400 $5.73 Million
Q3 2021

Nov 16, 2021

SELL
$41.3 - $54.56 $1.33 Million - $1.75 Million
-32,100 Reduced 10.3%
279,500 $11.8 Million
Q2 2021

Aug 16, 2021

BUY
$38.61 - $55.0 $8.15 Million - $11.6 Million
211,200 Added 210.36%
311,600 $16.9 Million
Q1 2021

May 18, 2021

BUY
$38.1 - $59.09 $3.83 Million - $5.93 Million
100,400 New
100,400 $4.56 Million

Others Institutions Holding ACCD

About Accolade, Inc.


  • Ticker ACCD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 71,938,896
  • Market Cap $266M
  • Description
  • Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and cli...
More about ACCD
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.